1.

2. 3. Patient no.AgeGenderDiagnosisEyeAVPreoperative IOPPostoperative IOP146FPostkeratoplasty glaucomaOS0,052828248FUveitisOS0,4297OSHM321216355MNeovascular glaucoma459FOACGOS0,140543FPostkeratoplasty glaucomaOD0.340669MPostkeratoplasty glaucomaODL5051MNeovascular glaucomaOS0.348FFPostkeratoplasty glaucomaFNeovascular glaucomaFailedBimatoprost +Timolol16Neovascular glaucomaComplications147Eyedrops8910678167ODODOS0,050,10.140405017TimololTube obstruction Tube obstruction1610Timolol+ Brimonidine20Bimatoprost +Timolol 4. Case serie 35.8 7,69mmHg (23-50) 103-month IOP (mmHg) Patients with Glaucoma eyedrops19,8 6,19mmHg (23-50) 56-month IOP (mmHg) Patients with Glaucoma eyedrops21,57 11,80mmHg (23-50) 412-month IOP (mmHg) Patients with Glaucoma eyedrops IOP NO. PATIENTS x ANTIGLAUCOMA EYEDROPSBaseline IOP (mmHg) Patients with Glaucoma eyedrops18,5 5,31mmHg (23-50) 545 40 35 30 25 20 15 10 5 0IOPNO. PATIENTS x ANTIGLAUCOMA EYEDROPSFOLLOW-UP 5. Authors (year)Drainage implantsStudy designNo.of eyesSuccess in % (IOP control)MoltenoRetrospective1060Smiddy et al. (1994)Molteno, BaerveldtRetrospective1090Luttrull and Avery (1995)Molteno, BaerveldtRetrospective22100Varma et al. (1995)BaerveldtRetrospective1385Sheppard et al. (1995)MoltenoRetrospective7100Kaynak et al. (1998)Molteno, SchocketRetrospective1794Sidoti et al. (2001)Molteno, Ahmed,Retrospective3485 (1 year),Studies using non-modified drainage implants Lloyd et al. (1991)Baerveldt, Krupin Surez-Fernndez et al. (2010)Molteno, Ahmed,62 (2 years) Retrospective887.5Studies using pars plana-modified drainage implants Luttrull et al. (2000)Baerveldt with Hofmann elbowRetrospective5094Chalam et al. (2002)Baerveldt with Hofmann elbowRetrospective9195Schlote et al. (2006)Ahmed PS2Retrospective1191Diaz et al. (2010) Faghihi et al. (2007) Dada et al. (2010)Ahmed PC 7Retrospective1090Ahmed S2 (16 eyes), S3 (2 eyes)Retrospective1872.2Ahmed PC 7(10 eyes), PC 8 (1 eye)Retrospective1181.8 6. 7. 8. 9. 10. MERCI BEACOUP